Loading…

Sepratec, a subsidiary of Enbionia, signed a contract on November 3, 2022 with a Chinese medical company to supply mass-production equipment for artificial lung membranes, valued at $1.51 million (approximately KRW 2.1 billion).
“이번 계약은 당사가 보유한 기술을 필요로 하는 산업분야가 점차 확대되고 있다는 반증”gametoc.co.kr
Summarized from public sources; check the original articles before acting on it.